MDXH
MDxHealth SA
0.582$
-3.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 35.1% | 34.9% | 39.2% | 39.6% | 38.8% | 38.0% | 36.2% | 34.0% | 34.8% | 46.4% | 46.4% | 34.3% | 42.4% | |
| 64.9% | 65.1% | 60.8% | 60.4% | 61.2% | 62.0% | 63.8% | 66.0% | 65.2% | 53.6% | 53.6% | 65.7% | 57.6% | |
| 8.0% | 2.6% | 10.9% | 12.1% | 11.6% | 11.4% | 10.3% | 9.6% | 7.3% | 18.9% | 18.9% | 7.3% | 15.1% | |
| 27.8% | 103.3% | 27.0% | 26.7% | 24.6% | 24.1% | 24.0% | 23.4% | 27.2% | 72.2% | 72.2% | 30.1% | 57.6% | |
| 88.4% | 93.1% | 94.1% | 93.8% | 87.3% | 84.3% | 82.7% | 73.2% | 74.8% | 74.8% | 74.8% | 84.5% | 76.4% | |
| -23.6% | -28.0% | -33.3% | -33.4% | -26.1% | -22.3% | -18.9% | -7.2% | -9.6% | -21.2% | -21.2% | -18.7% | -18.8% | |
| 31.3% | 27.0% | 16.5% | 11.1% | 21.3% | 14.9% | 21.3% | 23.6% | 21.4% | 15.3% | 15.3% | 22.3% | 17.5% | |
| -51.9% | -53.6% | -42.9% | -47.7% | -46.6% | -36.7% | -37.3% | -29.3% | -29.2% | -36.2% | -36.2% | -34.8% | -34.8% | |
| 9.8% | 0.0% | 0.0% | – | 1.4% | 0.8% | 0.6% | -1.6% | 0.0% | -1.9% | -1.9% | – | – | |
| -51.9% | -53.6% | -42.9% | -47.7% | -48.0% | -37.5% | -37.9% | -27.7% | -29.2% | -34.3% | -34.3% | -42.4% | -34.8% | |
| -11.0% | -44.0% | -16.8% | -21.3% | -16.1% | -12.8% | -6.8% | 2.9% | 2.5% | -12.3% | -12.6% | -3.7% | -8.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.